SpineX Announces Successful in-Human Results to Treat Adults with Cerebral Palsy Read More » January 3, 2024
ChemDiv Marks a Milestone as Orionis Biosciences’ Novel Immunotherapy Enters Phase I Clinical Trials Read More » January 3, 2024
AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System | Reports Boston Scientific as First-Line Treatment for Persistent Atrial Fibrillation Read More » December 29, 2023
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic Dermatitis Read More » December 17, 2023
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM Read More » December 17, 2023
Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2 Delivery Catheter Read More » December 15, 2023